Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

09:29
11/23/16
11/23
09:29
11/23/16
09:29

Eli Lilly falls sharply after solanezumab trial did not meet endpoint

The stock was last down over 15.6% to $63.99 to a new 52-week low. At that price $62.19 is next support. Resistance is at $65.54.

  • 04

    Dec

LLY Eli Lilly

11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.
11/23/16
JPMS
11/23/16
NO CHANGE
Target $85
JPMS
Overweight
JPMorgan sees 'attractive opportunity' amid Eli Lilly selloff
JPMorgan analyst Chris Schott lowered his price target for Eli Lilly to $85 from $95 after the phase III trial of solanezumab missed on both primary and secondary endpoints. Beyond solanezumab, Lilly has a diverse range of new product opportunities that support 5% sales and mid-teens earnings growth, Schott tells investors in a research note. With the shares down 13% to $65.81 in pre-market trading, the analyst sees an "attractive opportunity." He keeps an Overweight rating on Lilly.
11/23/16
JEFF
11/23/16
NO CHANGE
Target $100
JEFF
Buy
Eli Lilly still expects to grow revenue, says Jefferies
Jefferies analyst Jeffrey Holford says that while the solanezumab Phase III trial failure is disappointing, Eli Lilly management expects to grow revenue between 2015 and 2020 while expanding margins. Further, the company is still pursuing the Alzheimer's indication though a number of other programs, Holford tells investors in a research note. The analyst previously estimated a negative solanezumab trial outcome could see the stock down $12. Shares of Lilly are currently down $10.19 to $65.80 in pre-market trading. Holford keeps a Buy rating on Lilly with a $100 price target.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.

TODAY'S FREE FLY STORIES

JAGX

Jaguar Animal Health

$0.70

0.0373 (5.65%)

17:12
12/07/16
12/07
17:12
12/07/16
17:12
Syndicate
Jaguar Animal Health files to sell 6.67M shares of common stock for holders »

Of these shares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMSA

Fairmount Santrol

$9.27

-0.08 (-0.86%)

17:06
12/07/16
12/07
17:06
12/07/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Fairmount Santrol »

Point72 Asset reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

COVS

Covisint

$2.30

0.1 (4.55%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Covisint signs agreements with SAIC General Motors, NextEV »

Covisint Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$770.19

5.47 (0.72%)

17:01
12/07/16
12/07
17:01
12/07/16
17:01
Hot Stocks
Amazon launches menswear brand 'Buttoned Down' »

Amazon announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$32.65

-1.15 (-3.40%)

16:50
12/07/16
12/07
16:50
12/07/16
16:50
Hot Stocks
Breaking Hot Stocks news story on AMC Entertainment »

Monterey Capital III…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCFT

MCBC Holdings

$14.18

0.23 (1.65%)

16:43
12/07/16
12/07
16:43
12/07/16
16:43
Syndicate
MCBC Holdings files to sell 1M shares of common stock for holders »

B. Riley and Co. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.97

-0.03 (-0.17%)

16:42
12/07/16
12/07
16:42
12/07/16
16:42
Syndicate
Eagle Point Credit files to sell 1.15M shares of common stock »

Keefe, Bruyette &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:39
12/07/16
12/07
16:39
12/07/16
16:39
General news
Moody's changes outlook on Italy to negative from stable »

Moody's Investors…

DNB

Dun & Bradstreet

$123.83

2.42 (1.99%)

16:39
12/07/16
12/07
16:39
12/07/16
16:39
Hot Stocks
Dun & Bradstreet appoints CEO Robert Carrigan as chairman »

Dun & Bradstreet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIND

Mitcham Industries

$3.73

0.04 (1.08%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Earnings
Mitcham Industries reports Q3 EPS (62c), consensus (43c) »

Reports Q3 revenue $8.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$13.30

0.09 (0.68%)

16:35
12/07/16
12/07
16:35
12/07/16
16:35
Hot Stocks
Crescent Point Energy announces $1.45B CapEx budget for 2017 »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$24.58

0.59 (2.46%)

16:34
12/07/16
12/07
16:34
12/07/16
16:34
Hot Stocks
Corning announces $4B share repurchase program »

Corning announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTT

Wireless Telecom Group Inc

$1.58

0.01 (0.64%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Wireless Telecom Group Inc appoints Michael Kandell as CFO »

Wireless Telecom Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGS

Argos Therapeutics

$4.85

0.1 (2.11%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
Argos announces rocapuldencel-T as generic name for AGS-003 »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

WWE

WWE

$19.43

0.48 (2.53%)

16:33
12/07/16
12/07
16:33
12/07/16
16:33
Hot Stocks
WWE co-founder says appointed by Trump to lead Small Business Administration »

Linda McMahon, WWE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPC

W.P. Carey

$59.52

1.08 (1.85%)

16:31
12/07/16
12/07
16:31
12/07/16
16:31
Hot Stocks
W.P. Carey raises quarterly dividend to 99c per share »

W.P. Carey reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CM

CIBC

$83.70

1.28 (1.55%)

, PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Conference/Events
PrivateBancorp to host special shareholder meeting »

Special Shareholder…

CM

CIBC

$83.70

1.28 (1.55%)

PVTB

PrivateBancorp

$52.39

0.25 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

16:30
12/07/16
12/07
16:30
12/07/16
16:30
Options
Preliminary option volume of 21.5M today »

Preliminary option volume…

CMTL

Comtech

$12.75

0.77 (6.43%)

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Comtech declares 10c quarterly dividend, sees FY17 quarterly dividends unchanged »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

SKLN

Skyline Medical

16:26
12/07/16
12/07
16:26
12/07/16
16:26
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Nations Advisory Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

River North Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Hot Stocks
Breaking Hot Stocks news story on Skyline Medical »

Kodiak Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$21.15

-0.02 (-0.09%)

16:25
12/07/16
12/07
16:25
12/07/16
16:25
Conference/Events
William Blair software/SaaS analyst holds a tech roundtable dinner meeting »

Software/SaaS Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

TYL

Tyler Technologies

$147.73

1.54 (1.05%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Hot Stocks
Tyler Technologies rejects media reports of issues with Odyssey product »

Tyler Technologies issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

HRB

H&R Block

$23.34

0.65 (2.86%)

16:24
12/07/16
12/07
16:24
12/07/16
16:24
Earnings
H&R Block reports Q2 continuing ops EPS (67c), consensus (68c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.